Position in MRK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,478,482
+$238,140 QoQ
Shares Held
34,852
-1.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#1,101
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TOWER BRIDGE ADVISORS holds $63,752,721 across 8 Drug Manufacturers - General names. MRK ranks #6 (7.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
89,561 | $22,745,806 | |
| 2 | NVS |
Novartis AG
|
69,416 | $10,878,875 | |
| 3 | ABBV |
AbbVie Inc.
|
38,900 | $9,788,796 | |
| 4 | LLY |
ELI LILLY & Co
|
6,601 | $7,917,438 | |
| 5 | AMGN |
Amgen Inc
|
15,102 | $5,468,736 | |
| 6 | MRK |
Merck & Co., Inc.
This page
|
34,852 | $4,478,482 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
26,527 | $1,528,485 | |
| 8 | PFE |
Pfizer Inc
|
39,290 | $946,103 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,478,482 | 34,852 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $4,240,342 | 35,251 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $3,782,518 | 35,935 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,020,053 | 35,983 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,110,433 | 39,293 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $3,937,412 | 43,866 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $4,781,605 | 48,066 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $5,507,660 | 48,500 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $5,830,361 | 47,095 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $6,354,316 | 48,157 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $5,304,477 | 48,656 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,080,891 | 49,353 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $5,838,734 | 50,600 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $6,910,668 | 64,956 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $7,040,443 | 63,456 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $5,483,518 | 63,673 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,862,504 | 64,303 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $5,233,559 | 63,785 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $4,854,454 | 63,341 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $4,853,608 | 64,620 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $5,035,996 | 64,755 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $5,013,550 | 65,035 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $5,425,627 | 66,328 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $3,341,061 | 40,278 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $3,093,819 | 40,008 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $3,301,340 | 42,908 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||